Praxis Pharmaceutical, S.A.
http://www.grupo-praxis.com/en/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Praxis Pharmaceutical, S.A.
Deal Watch: Allergan Keeps After Hair Loss With Exicure Deal
Allergan has tried to go after alopecia in the past; Exicure brings a new spherical nucleic acid (SNA) technology. In other recent deals, AstraZeneca sells Seroquel, Losec rights to Germany’s Cheplapharm.
Acumen raises $20m Series A for Alzheimer's antibody
Acumen Pharmaceuticals completed the first closing a $20 million Series A funding round, which will be used to demonstrate proof of concept for the monoclonal antibody ACU-193 in the treatment of Alzheimer's disease by 2016.
Patient fees in Estonia to rise next year
As the budget of Estonia's health insurance fund, the Haigekassa, is to be cut by 6% next year, patient fees for hospital stays are to be increased to Eek100 ($9.40) per day from the beginning of next year. At present, they are Eek25 per day during the first 10 days in hospital, and children and teenagers under 19 years of age, pregnant women and patients in intensive care wards are exempt.
Company Information
- Industry
- Contract Manufacturing Organization
- Other Names / Subsidiaries
-
- PRX Pharma Produtos Farmacêuticos Unipessoal, LDA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice